Is Mogamulizumab included in medical insurance?

Mogamulizumab is a drug used to treat a specific type of lymphoma. It is widely used clinically to fight T cell lymphoma, a subtype of malignant lymphoma that usually originates from T lymphocytes. Moglizumab has a unique mechanism that inhibits the proliferation and survival of malignant T cells by targeting the CCR4 receptor, thereby alleviating symptoms and improving patient survival rates.

Moglizumab is already on the market in China, but it is not covered by medical insurance. Please consult your local hospital pharmacy for specific prices.

Moglizumab's main mechanism of action is by targetingCCR4receptor. The CCR4 receptor is often overexpressed in T cell lymphomas and is therefore a target for therapy. This drug binds to the CCR4 receptor and interferes with signaling pathways within the receptor, thereby reducing the growth and division of malignant T cells. In addition, moglizumab can also activate the body's immune system and enhance the attack of natural killer cells (NK cells) and other immune cells against malignant T cells, further enhancing the therapeutic effect.

The efficacy of moglizumab is supported by multiple clinical trials. One of the most notable trials was the MAVORIC trial, which confirmed the efficacy of moglizumab in patients with relapsed PTCL. In addition, the MAVORIC-CTCL trial also showed the efficacy of moglizumab in patients with relapsed or progressive CTCL. These trial results provide a solid scientific basis for moglizumab as an important option for the treatment of specific lymphoma types.

Although moglizumab is excellent in treating lymphoma, it is associated with some side effects, including allergic reactions, skin reactions, risk of infection, and abnormal liver function. Therefore, when using moglizumab, patients need to strictly follow the doctor's recommendations and undergo regular monitoring and evaluation to ensure the safety and effectiveness of the drug. Doctors manage these side effects on a patient-by-case basis to minimize their impact on patients, thereby providing a better treatment experience and efficacy.